ClinicalTrials.gg
Not yet recruitingNCT06157229MATASIUpdated Dec 5, 2023

Multifactorial Approach Training for Anterior Shoulder Instability in Patients Undergoing Arthroscopic Bankart Repair

An interventional study of MAT and CABRR in Shoulder Instability, Shoulder Dislocation or Subluxation and Fear of Movement, sponsored by Spaarne Gasthuis. Not yet recruiting. Open to participants aged 18 Years to 67 Years. Per ClinicalTrials.gov, last updated 2023-12-05.

Sponsored by Spaarne Gasthuis · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 67 Years
Sex
All
01

Study summary

This study will compare functional outcomes after an arthroscopic Bankart repair between patients that underwent conventional arthroscopic Bankart repair rehabilitation, following the American Society of Shoulder and Elbow Therapists guideline and patients that underwent 'multifactorial approach training', which focusses on decreasing kinesiophobia and fear of recurrent dislocations.

The study population comprises patients who will undergo Arthroscopic Bankart Repair (ABR) after a traumatic anterior shoulder dislocation at Spaarne Gasthuis Haarlem/Hoofddorp, OLVG Amsterdam, Amstelland Ziekenhuis Amstelveen, Gelre Ziekenhuizen, Medisch Spectrum Twente, or Flevoziekenhuis Almere.

Read the detailed description

Background: Fear for (recurrent) dislocation is a frequently reported patient perception regarding the treatment of anterior shoulder instability and is associated with poor outcomes like decrease in quality of life and unsuccesful return to sport. There is lack of standard multifactorial aftercare of shoulder instability surgery incorporating the psychological component of the experiences trauma of patients with shoulder instability. Therefore, a newly developed Rehabilitation Protocol (REPRO) aims to reduce fear for dislocation in order to increase psychological readiness to return to sport. The aim of this study is to compare the effect on the psychological readiness to return to sport between our new Multifactorial Approach Training (MAT) and Conventional Arthroscopic Bankart Repair Rehabilitation (CABRR) in a single-blinded, multi-center randomized controlled trial.

Methods: Patients, aged 18-67 years, with traumatic anterior shoulder instability, undergoing ABR will be included. Rehabilitation is started within 4 weeks following surgical treatment. Patients will be randomized to either the control group (A) or the MAT group (B). Group A will receive CABRR, according to the American Society of Shoulder and Elbow Therapists (ASSET) guidelines. Group B will receive MAT, following the REPRO. A total of 92 patients will be included, with 46 patients per study arm. Patients will be followed-up for 52 weeks. The primary outcome is change from baseline (surgical intervention; ABR) in Shoulder Instability Return to Sport Index (SIRSI) at 26 weeks postoperatively. Secondary outcomes include Oxford Shoulder Instability Score (OSIS), Subjective Shoulder Value (SSV), fear for dislocation measured with a Numeric Rating Scale (NRS), Tampa Scale of Kinesiophobia in patients with Shoulder Instability (TSK-SI), World Health Organization Quality of Life Questionnaire - BREF (WHOQoL-BREF), Return To Work (RTW), Return To Sports (RTS), shoulder pain measured with a NRS, , number of physiotherapy and outpatient clinic visits and patient satisfaction (VAS). At baseline and at 26 weeks postoperatively patients will undergo a task-based brain activity analysis using functional Magnetic Resonance Imaging (fMRI) to determine functional cerebral changes after treatment. The MATASI trial is to be conducted between 2024 and 2026.

02

Conditions studied

  • Shoulder Instability
  • Shoulder Dislocation or Subluxation
  • Fear of Movement
  • Kinesiophobia
03

In context

Shoulder Dislocation

105 studies on the registry are indexed under Shoulder Dislocation; 22 are open to participants now.

This study's planned enrollment of 100 is above the median of 60 across 71 interventional studies indexed under Shoulder Dislocation.

Browse Shoulder Dislocation studies →

Lead sponsor

Spaarne Gasthuis is the lead sponsor of 11 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 67 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primary or recurrent traumatic anterior shoulder dislocation (MRI-confirmed labral tear)
  • Aged between 18-67 years
  • Planned arthroscopic Bankart repair (ABR) surgery
  • Understanding of spoken and written Dutch language
  • Written (according to the ICH-GCP guidelines)
  • Positive apprehension sign at physical examination

Exclusion criteria

Exclusion Criteria:

  • Posterior or multidirectional shoulder instability
  • Presence of hyperlaxity of the upper extremity and absence of sulcus sign and >85 degrees of external rotation with the arm at the side at physical examination
  • Connective tissue disorders (e.g. Ehlers-Danlos)
  • Aged \<18 or >67 years
  • Assymetry in rotator cuff strength, bilateral component ((sub)luxations on contralateral side)
  • History of soft tissue repair or bone block procedure on one of both shoulders
  • Current or past anxiety disorders or use of anxiety supressing drugs (e.g. anti-psychotics)
  • Implantable cardioverter defibrillator (ICD) (unable to be included for functional MRI)
  • Neurological disorders or systemic disease
  • Loss of anteroinferior sclerotic contour of the glenoid on AP view of the shoulder
  • Hill-Sachs lesion visible on external rotation radiographs
  • Greater tubercle fracture
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Multifactorial Approach Training (MAT)

    MAT involves an evidence-based core outcome-set of interventions aimed at both regaining functional stability of the shoulder and also diminishing fear of (recurrent) dislocation and kinesiophobia. The protocol is based on a recent international Delphi-based consensus study, initiated since no protocol yet existed focusing on this psychological component of traumatic anterior shoulder instability.

    Other: MAT

  • Active comparator
    Conventional Arthroscopic Bankart Repair Rehabilitation (CABRR)

    The original guidelines which most physiotherapists use throughout the rehabilitation of their patients following ABR is the ASSET guideline \[2\].

    Other: CABRR

Interventions

  • OtherMAT

    The protocol consists of four phases: 1) immobilization phase, 2) early protective phase, 3) intermediate phase and 4) late phase. The detailed guideline can be found in the following article: Gaunt, B. W., Shaffer, M. A., Sauers, E. L., Michener, L. A., McCluskey, G. M., \& Thigpen, C. A. (2010). The American Society of Shoulder and Elbow Therapists' Consensus Rehabilitation Guideline for Arthroscopic Anterior Capsulolabral Repair of the Shoulder. Journal of Orthopaedic \& Sports Physical Therapy, 40(3), 155-168. https://doi.org/10.2519/jospt.2010.3186

  • OtherCABRR

    The protocol consists of four phases: 1) immobilization phase, 2) early phase, 3) intermediate phase and 4) advanced phase. The protocol comprises education, modified cognitive behavioral therapy, neuromuscular control exercises, kinetic chain exercises, range of motion enhancing exercises, strength and conditioning exercises, and sport-specific exercises. The protocol is currently unpublished.

06

What researchers measure

Primary outcomes

  1. Shoulder Instability Return to Sport Index (SIRSI)

    Patient reported outcome measure to assess psychological readiness to return to sport in patients with shoulder instability

    Time frame: 26 weeks postoperative

Secondary outcomes

  1. Oxford Shoulder Instability Score (OSIS)

    Patient reported shoulder function between MAT and CABRR

    Time frame: 26 and 52 weeks postoperative

  2. Shoulder function, measured by Subjective Shoulder value (SSV)

    Shoulder function, measured by Subjective Shoulder value (SSV)

    Time frame: baseline, 26 and 52 weeks postoperative

  3. Fear of recurrent dislocation, measured by Numeric Rating Scale (NRS)

    Fear of recurrent dislocation, measured by Numeric Rating Scale (NRS)

    Time frame: baseline, 26 and 52 weeks postoperative

  4. Tampa Scale for Kinesiophobia in patients with Shoulder Instability (TSK-SI)

    Patient reported outcome measure to assess the degree of kinesiophobia

    Time frame: baseline, 26 and 52 weeks postoperative

  5. World Health Organization Qualitiy of Life Questionnaire - BREF (WHOQoL-BREF)

    Patient reported outcome measure to assess the self reported quality of life

    Time frame: baseline, 26 and 52 weeks postoperative

  6. Level of shoulder pain measured by Visual Analogue Scale (VAS)

    Level of shoulder pain measured by Visual Analogue Scale (VAS)

    Time frame: baseline, 26 and 52 weeks postoperative

  7. Number of patients that return to work (RTW) following the surgery

    Number of patients that return to work (RTW) following the surgery

    Time frame: 26 and 52 weeks postoperative

  8. Number of patients tha return to sport (RTS) following the surgery

    Number of patients tha return to sport (RTS) following the surgery

    Time frame: 26 and 52 weeks postoperative

  9. Patient satisfaction regarding the surgical treatment and rehabilitation, measured by VAS

    Patient satisfaction regarding the surgical treatment and rehabilitation, measured by VAS

    Time frame: baseline, 26 weeks and 52 weeks postoperative

  10. The number of physiotherapy and orthopedic surgeon visits

    The number of physiotherapy and orthopedic surgeon visits

    Time frame: From start to end of treatment

  11. Task-based brain activity, measured in voxels

    Analysis using functional Magnetic Resonance Imaging (fMRI) to determine functional cerebral changes after treatment

    Time frame: baseline and 26 weeks postoperative

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Gaunt BW, Shaffer MA, Sauers EL, Michener LA, McCluskey GM, Thigpen C; American Society of Shoulder and Elbow Therapists. The American Society of Shoulder and Elbow Therapists' consensus rehabilitation guideline for arthroscopic anterior capsulolabral repair of the shoulder. J Orthop Sports Phys Ther. 2010 Mar;40(3):155-68. doi: 10.2519/jospt.2010.3186. PubMed 20195022 ↗
  • van Iersel TP, Tutuhatunewa ED, Kaman I, Twigt BA, Vorrink SN, van den Bekerom MP, van Deurzen DF. Patient perceptions after the operative and nonoperative treatment of shoulder instability: A qualitative focus group study. Shoulder Elbow. 2023 Oct;15(5):497-504. doi: 10.1177/17585732221122363. Epub 2022 Aug 24. PubMed 37811392 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2024; primary completion for Dec 2026, 35 months later.

Of 39 non-industry interventional studies with no phase under Shoulder Dislocation, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 35 months is above that.

Counting every sponsor, half of 39 studies reached it within 22 months; a quarter within 11 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 20, 2023
First posted
Dec 5, 2023
StartEst.
Jan 1, 2024
Primary completionEst.
Dec 1, 2026
CompletionEst.
Jun 1, 2027
Last update
Dec 5, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06157229
Lead sponsor
Spaarne Gasthuis
Collaborators
OLVG, Ziekenhuis Amstelland, Gelre Hospitals, Medisch Spectrum Twente, Flevoziekenhuis
Responsible party
Sponsor
First posted
Dec 5, 2023
Start date
Jan 1, 2024 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Dec 5, 2023

Study contacts

Madu N Soares, BSc.
Contact
msoaresfilho@spaarnegasthuis.nl
+31648164073
Theodore P van Iersel, MD
Contact
vanierselted@gmail.com
+31614564784
Arthur van Noort, MD PhD
principal investigator · Orthopedic Surgeon and Head of Residency Program, Spaarne Gasthuis

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion